It was demonstrated that HDAC inhibitor treatment could result in increased cPAcP protein level in cPAcP positive cells, increase androgen responsiveness, and exhibit higher inhibitory activities on AR/cPAcP-positive PCa cells than on AR/cPAcP-negative PCa cells. The gene discussed is AR; the disease is posterior cortical atrophy.